✦ LIBER ✦

Treatment planning for dose escalation in non-small cell lung cancer (NSCLC)

✍ Scribed by Steven E. Schild; Shawn M. Korte; William W. Wong; Sujay A. Vora; James A. Younggren; Gary A. Ezzell

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

14. The challenge of dose escalation for

✍ P. Van Houtte; M. Roelandts; C. Mahin 📂 Article 📅 2003 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 97 KB

113 Dose escalation for non-small cell l

✍ John M. Robertson; Andrew T. Turrisi; Mark B. Hazuka; Mary K. Martel; Randall K. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 102 KB

The treatment of stage III non-small cel

✍ Gregory S. Sibley; Arno J. Mundt; Srinivasan Vijayakumar; Emmanuel Lazaridis; Ra 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 208 KB

Safety and feasibility of radiotherapy t

✍ F. Fiorica; F. Cartei; S. Ursino; A. Stefanelli; Y. Zagatti; S. Berretta; S. Fig 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 403 KB

Adjuvant treatments for non-small cell l

✍ Paul Van Houtte; F. Mornex; M. Roelandts 📂 Article 📅 2001 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 169 KB

Neoangiogenesis: A putative marker of ma

✍ Gabriella Fontanini; Silvana Vignati; Daniela Bigini; Marco Lucchi; Alfredo Muss 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 542 KB